Home » Topics » Regulatory » EMA

EMA
RSS

Pfizer withdraws application to extend Macugen indication in E.U.

July 20, 2011

COMP recommends orphan drug status for Nektar Therapeutics' lead oncology agent in ovarian cancer

July 19, 2011

BioAlliance gives update on Livatag and Clonidine Lauriad

July 14, 2011

Advanced Cell Technology's RPE cells gain E.U. orphan drug status in Stargardt's macular dystrophy

July 7, 2011

CHMP adopts positive opinion on new Kiovig indication in multifocal motor neuropathy

July 1, 2011

CHMP recommends approval of Eurartesim for malaria

June 30, 2011

EMA accepts tesamorelin MAA for review

June 29, 2011

Amgen obtains positive CHMP opinion on Vectibix after reexamination

June 29, 2011

CHMP adopts positive opinion on Buccolam

June 29, 2011

CHMP issues negative opinion on Bronchitol for cystic fibrosis

June 28, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...